Screening compound: MFMYSMSXYCVCCL-UHFFFAOYSA-N

Screening compound: MFMYSMSXYCVCCL-UHFFFAOYSA-N
Screening compound: MFMYSMSXYCVCCL-UHFFFAOYSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
MFMYSMSXYCVCCL-UHFFFAOYSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C607-0855

Molecular Formula

C20H21N3O2S (C20 H21 N3 O2 S)

Compound Name

2-(5,6,7,8-tetrahydro-2-naphthalenylsulfonyl)-1,2,3,4-tetrahydropyrazino[1,2-a][1,3]benzimidazole

IUPAC name

11-(5678-tetrahydronaphthalene-2-sulfonyl)-1811-triazatricyclo[7.4.0.0^{27}]trideca-2(7)358-tetraene

SMILES

O=S(c1cc(CCCC2)c2cc1)(N1Cc2nc(cccc3)c3n2CC1)=O

InChI

InChI=1S/C20H21N3O2S/c24-26(25,17-10-9-15-5-1-2-6-16(15)13-17)22-11-12-23-19-8-4-3-7-18(19)21-20(23)14-22/h3-4,7-10,13H,1-2,5-6,11-12,14H2

InChI Key

MFMYSMSXYCVCCL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14775342

MFMYSMSXYCVCCL-UHFFFAOYSA-N in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Anti-infective Library (19449 compounds)

Antiviral HBV Library (10007 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

DGK Inhibitors Library (10558 compounds)

GPCR Targeted Library (31838 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Immune system
  • animal
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Kinases
  • GPCR
  • Others
Mechanism of action:
  • Receptor's ligands
  • Epigenetic

References: we are preparing a list of scientific research reports with MFMYSMSXYCVCCL-UHFFFAOYSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound MFMYSMSXYCVCCL-UHFFFAOYSA-N?
Check Price and Availability of MFMYSMSXYCVCCL-UHFFFAOYSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of MFMYSMSXYCVCCL-UHFFFAOYSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for MFMYSMSXYCVCCL-UHFFFAOYSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for MFMYSMSXYCVCCL-UHFFFAOYSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of MFMYSMSXYCVCCL-UHFFFAOYSA-N available by request